首页> 外国专利> PREDICTING CANCER RECURRENCE USING A PROGNOSTIC MODEL THAT COMBINES IMMUNOHISTOCHEMICAL STAINING AND GENE EXPRESSION PROFILING

PREDICTING CANCER RECURRENCE USING A PROGNOSTIC MODEL THAT COMBINES IMMUNOHISTOCHEMICAL STAINING AND GENE EXPRESSION PROFILING

机译：使用结合免疫组织化学染色和基因表达谱的预后模型预测癌症复发

页面导航

摘要
著录项
相似文献

摘要

Predicting cancer recurrence using a prognostic model that combines immunohistochemical staining and gene expression profiling;Disclosed is an in vitro method for determining a risk of a cancer patient of a cancer recurrence. Further disclosed is a method of generating a network of prognostic features for cancer recurrence of a cancer patient. More particularly, disclosed is the prediction of prostate cancer recurrence using a prognostic model that combines immunohistochemical staining and gene expression profiling.

机译：使用结合了免疫组织化学染色和基因表达谱的预后模型预测癌症复发;公开了一种用于确定癌症患者癌症复发风险的体外方法。进一步公开了一种生成用于癌症患者的癌症复发的预后特征的网络的方法。更具体地，公开了使用结合了免疫组织化学染色和基因表达谱的预后模型对前列腺癌复发的预测。 展开▼

著录项

公开/公告号EP3533883A1

专利类型

公开/公告日2019-09-04

原文格式PDF

申请/专利权人 DEFINIENS AG;
展开▼

申请/专利号EP20150006736

发明设计人 SCHMIDT GÜNTER;
展开▼

申请日2019-02-12

分类号C12Q1/6886;G01N33/574;G16H50/20;G16B25/10;G16B5/20;G16B5/10;

国家 EP

入库时间 2022-08-21 12:26:45

相似文献

专利

外文文献

中文文献

1. 基于p53状态与基因表达谱的关联而用于分类、预后和诊断癌症的方法、系统和阵列 [P] . 中国专利： CN101111604A . 2008-01-23

2. 用于前列腺癌复发的预后的基因表达面板 [P] . 中国专利： CN112322735A . 2021-02-05

3. Predicting Prostate Cancer Recurrence Using a Prognostic Model that Combines Immunohistochemical Staining and Gene Expression Profiling [P] . 美国专利： US2019252044A1 . 2019-08-15

机译：结合免疫组织化学染色和基因表达谱分析的预后模型预测前列腺癌的复发

4. Predicting Prostate Cancer Recurrence Using a Prognostic Model that Combines Immunohistochemical Staining and Gene Expression Profiling [P] . 美国专利： US2019252075A1 . 2019-08-15

机译：结合免疫组织化学染色和基因表达谱分析的预后模型预测前列腺癌的复发

5. Prognostic methods for predicting recurrence of cancer in a patient, the initiator, amplicon, testing, use, method for predicting the survival time of patients with breast cancer without recurrence, prognostic model to predict survival time of patient of cancer of a And the breast without relapse, method of obtaining data for targeting treatment of breast cancer.Set of genes and laboratory kit. [P] . BR102013029251A2 . 2016-08-02

机译：用于预测患者癌症复发的预后方法，引发剂，扩增子，测试，用途，用于预测无复发的乳腺癌患者的生存时间的方法，用于预测a癌症患者的生存时间的预后模型和没有复发，获得用于靶向治疗乳腺癌的数据的方法。基因集和实验室试剂盒。

1. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer:the expression of BCL-2,E-cadherin,Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors [J] . Joseph Nariculam, Mark Feneley, Alex Freeman, 亚洲男性学杂志（英文版） . 2009,第001期

2. Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer [J] . Yamashita Kohei, Iwatsuki Masaaki, Harada Kazuto, Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2020,第1期

3. Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles [J] . Quan Chen, Peng Gao, Yongxi Song, Cancer Medicine . 2020,第9期

4. Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma. [J] . Zhang L, Higashi K, Ishigaki Y, Annals of nuclear medicine . 2010,第7期

5. COMBINING GENE EXPRESSION AND CLINICAL DATA TO INCREASE PERFORMANCE OF PROGNOSTIC BREAST CANCER MODELS [C] . Jana Silhava, Pavel Smrz International Conference on Agents and Artificial Intelligence . 2012

6. Constructing gene expression based prognostic models to predict recurrence and lymph node metastasis in colon cancer. [D] . Mettu, Ramakanth Reddy. 2008

7. Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles [O] . Quan Chen, Peng Gao, Yongxi Song, 2020

8. Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer [O] . Kohei Yamashita, Masaaki Iwatsuki, Kazuto Harada, 2019

1. Prognostic Value of Combined;Cox-2, Cyclin D1 and P21 Expression in Colorectal Cancer (CRC) Patients: An Immunohistochemical Study [J] . Amir M. Salem ,Mariem A. Elfeky ,Nashwa Nawar . 病理学期刊（英文） . 2018,第3期

2. Gene Expression Profiles Predict Sensitivity of Prostate Cancer to Radiotherapy [J] . Lilach Agemy ,Itai Kela ,Tova Waks . 癌症治疗（英文） . 2013,第4期

3. Expression of the chemoresistance-related proteins and p53 gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer at the stages of II-IV [J] . MA Jia-jia ,CHEN Bi-liang ,XIN Xiao-yan . 生命科学（ISSN1934-7391） . 2008,第005期

4. Gene expression profiling of gastric cancer by microarray combined with laser capture microdissection [J] . Ming-Shiang Wu ,Yi-Shing Lin ,Yu-Ting Chang . 世界胃肠病学杂志：英文版 . 2005,第47期

5. 康莱特抗小鼠癌症恶病质相关基因表达谱研究 [C] . 吴煜 ,杨宇飞 ,邬冬华 . 第二届国际中西医结合、中医肿瘤学术研讨会 . 2004

6. 基于基因表达谱和miRNA表达谱的癌症分类集成预测方法 [A] . 师哲 . 2018